Potential of ginsenoside Rg1 to treat aplastic anemia via mitogen activated protein kinase pathway in cyclophosphamide-induced myelosuppression mouse model

doi:10.4252/wjsc.v16.i11.900

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (149)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=88

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=37

Publishing Process of This Article

Item

Count

Browse

Download

Sum=20

Nov 26, 2024 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Stem Cells. Nov 26, 2024; 16(11): 900-905
Published online Nov 26, 2024. doi: 10.4252/wjsc.v16.i11.900

Potential of ginsenoside Rg1 to treat aplastic anemia via mitogen activated protein kinase pathway in cyclophosphamide-induced myelosuppression mouse model

See-Hyoung Park

See-Hyoung Park, Biological and Chemical Engineering, Hongik University, Sejong 30016, South Korea

Author contributions: Park SH designed the overall concept and outline of the manuscript; Park SH contributed to the discussion and design of the manuscript, the writing, editing, and reviewing the manuscript.

Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: See-Hyoung Park, Associate Professor, PhD, Biological and Chemical Engineering, Hongik University, Sejongro 2639, Sejong 30016, South Korea. shpark74@hongik.ac.kr

Received: August 21, 2024
Revised: October 12, 2024
Accepted: November 20, 2024
Published online: November 26, 2024
Processing time: 97 Days and 6 Hours

Core Tip

Core Tip: An animal model of aplastic anemia was established in mice using cyclophosphamide, and pathological changes in the bone marrow were analyzed using hematoxylin-eosin staining of the tissues. Blood samples were collected from the mice to analyze blood cell composition. This study also examined the changes in cellular components and protein expression in the mitogen activated protein kinase signaling pathway within the bone marrow to determine whether ginsenoside Rg1 can mitigate myelosuppression through the mitogen activated protein kinase pathway.